Pacific Edge Limited
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Pacific Edge Limited sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Pacific Edge Limited: 6 sponsored US clinical trials, 3 recruiting.
Pacific Edge Limited sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Urothelial Carcinoma, with 3 trials.
Upper-quartile sponsor footprint
Pacific Edge Limited sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
NCT06394869
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
NCT05889195
Longitudinal Bladder Cancer Study for Tumour Recurrence
NCT05080998
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
NCT04943380
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA
NCT03988309
The Cxbladder Monitoring Study
NCT02700659
Therapeutic Areas
What is open in the Pacific Edge Limited pipeline
3 recruiting of 6 indexed (50% open); 3 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Urothelial Carcinoma (3 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Pacific Edge Limited: open-pipeline peers nationwide
Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Pacific Edge Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Pacific Edge Limited page
6 registered trials is a research-attention snapshot, not an endorsement of Pacific Edge Limited or any single study.
- 3 of Pacific Edge Limited's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urothelial Carcinoma is the condition Pacific Edge Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urothelial Carcinoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pacific Edge Limited pipeline card: 6 registered trials from official public datasets.Report a data error.